A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus

Radiotherapy and Oncology

Volumn 57, Issue 2, 2000, Pages 183-193

  Bedford, James L ^a   Viviers, Louis ^a   Guzel, Zuzanna ^b   Childs, Peter J ^a   Webb, Steve ^a   Tait, Diana M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Conformal radiotherapy; Dose escalation; Lung; Normal tissue complication probability; Oesophagus; Tumour control probability

Indexed keywords

CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; HUMAN; LUNG TOXICITY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT PLANNING;

EID: 0034332873     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00258-9     Document Type: Article

References (64)

1. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study
2. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer
3. Strategy for dose escalation using three-dimensional conformal radiation therapy for lung cancer
4. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
5. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus
6. Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging
7. A digital method for computing target margins in radiotherapy
8. VIRTUOS - a program for virtual radiotherapy simulation and verification
9. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury
10. Decomposition of pencil beam kernels for fast dose calculations in three-dimensional treatment planning
11. Fitting of normal tissue tolerance data to an analytic function
12. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study
13. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy
14. Significance of prone positioning in planning treatment for esophageal cancer
15. Factors influencing outcome following radio-chemotherapy for oesophageal cancer
16. Conformal radiotherapy of stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams
17. An approach to the interpretation of clinical data on the tumor control probability-dose relationship
18. Tolerance of normal tissue to therapeutic irradiation
19. Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy
20. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus
21. The linear-quadratic formula and progress in fractionated radiotherapy
22. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report
23. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery
24. Predicting radiation response
25. Regarding predicting radiation response
26. A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress
27. Esophageal stricture following high-dose-rate intracavitary irradiation for esophageal cancer
28. Esophageal fistula associated with intracavitary irradiation for esophageal carcinoma
29. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine
30. Comparative treatment planning between proton and X-ray therapy in esophageal cancer
31. Hyperfractionation and accelerated radiotherapy
32. Respiration gated radiotherapy treatment: a technical study
33. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method
34. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients
35. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis
36. The impact of local tumor control on the outcome in human cancer
37. The biological basis for conformal three-dimensional radiation therapy
38. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach
39. Complication probability as assessed from dose-volume histograms
40. The incidence of myelitis after irradiation of the cervical spinal cord
41. Physical and biological predictors of changes in whole-lung function following thoracic irradiation
42. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
43. Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning
44. Volume and dose parameters for survival of non-small cell lung cancer patients
45. Overview: the changing nature of esophageal cancer
46. Radiation tolerance of the cervical spinal cord
47. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
48. Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group study (SWOG-8037)
49. Comparison of three treatment strategies for esophageal cancer within a single institution
50. Dose escalation for non-small cell lung cancer using conformal radiation therapy
51. An audit of the treatment of cancer of the oesophagus
52. Spinal cord radiation 'tolerance': doctrine versus data
53. Spinal cord radiation tolerance
54. The treatment of stage III non-small cell lung cancer using high dose conformal radiotherapy
55. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group
56. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery
57. Variability of target volume delineation in cervical esophageal cancer
58. Use of V(eff) and iso-NTCP in the implementation of dose escalation protocols
59. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer
60. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density
61. The hazard of accelerated tumor clonogen repopulation during radiotherapy
62. Radiation myelopathy following single courses of radiotherapy and retreatment
63. Endoscopic diagnosis of 115 cases of early oesophageal carcinoma